Warning: Undefined variable $page_cluster_id in /home3/thegood9/public_html/website_70aad9ea/header.php on line 29



Warning: Undefined variable $subreddit_drop in /home3/thegood9/public_html/website_70aad9ea/functions.php on line 998

Warning: Undefined variable $subreddit_drop in /home3/thegood9/public_html/website_70aad9ea/functions.php on line 998

Warning: Undefined variable $subreddit_drop in /home3/thegood9/public_html/website_70aad9ea/functions.php on line 998

Warning: Undefined variable $subreddit_drop in /home3/thegood9/public_html/website_70aad9ea/functions.php on line 998

Warning: Undefined variable $subreddit_drop in /home3/thegood9/public_html/website_70aad9ea/functions.php on line 998

Warning: Undefined variable $subreddit_drop in /home3/thegood9/public_html/website_70aad9ea/functions.php on line 998

Warning: Undefined variable $subreddit_drop in /home3/thegood9/public_html/website_70aad9ea/functions.php on line 998

Warning: Undefined variable $subreddit_drop in /home3/thegood9/public_html/website_70aad9ea/functions.php on line 998

Warning: Undefined variable $subreddit_drop in /home3/thegood9/public_html/website_70aad9ea/functions.php on line 998

Warning: Undefined variable $subreddit_drop in /home3/thegood9/public_html/website_70aad9ea/functions.php on line 998

Warning: Undefined variable $subreddit_drop in /home3/thegood9/public_html/website_70aad9ea/functions.php on line 998

Warning: Undefined variable $subreddit_drop in /home3/thegood9/public_html/website_70aad9ea/functions.php on line 998

Warning: Undefined variable $subreddit_drop in /home3/thegood9/public_html/website_70aad9ea/functions.php on line 998

Saturday, May 16, 2026




In Detail Full day, Saturday, May 16, 2026, Timezone: America/Chicago


Data-Driven Decision Support in Obesity Management Commission: enabling more equitable and personalized obesity care

Paul W. Franks / nature - Nature Medicine, Published online: 12 May 2026; doi:10.1038/s41591-026-04363-0Announced in this Comment and in collaboration with Nature Medicine is the convening of the Data-Driven Decision Support in Obesity Management Commission, to promote adequate sc…

AI Summary: A phase 1/2 study of CRISPR‑Cas9 CD33‑deleted allogeneic hematopoietic cell transplantation followed by gemtuzumab ozogamicin maintenance reports encouraging early signals in AML. The gene‑editing approach aims to protect donor cells from CD33‑targeted therapy, potentially enabling safer post‑transplant maintenance and offering a novel strategy to marry cellular engineering with targeted antibody therapy.

#pharmaceuticals #biotech #drugdevelopment #oncology #cancerresearch #clinicaltrials #genetherapy #genetics

CD33‑targeted transplant and post‑transplant maintenance

8 days / oncodaily

11 days / oncodaily

14 days / oncodaily

19 days / medicalxpress


Safety and ethical scrutiny of gene editing and gene therapy

9 days / oncodaily


Scaling cell therapy: accreditation and expanding CAR indications


All Other Stories

2 days / esmo

3 days / nature

3 days / newscientist

6 days / oncodaily

6 days / oncodaily

6 days / medicalxpress

7 days / oncodaily

7 days / oncodaily

8 days / oncodaily


Back to Top / Saturday, May 16, 2026, 5:21 pm / permalink 23912 / 24 stories in 15 days /

When should you get a mammogram? Conflicting advice makes it hard to know

medicalxpress - Deciding when to get routine mammograms is confusing. Some health groups recommend women begin at age 40 or 45 while another recently opted for age 50. They also differ on whether yearly or every other year is best.

AI Summary: Conflicting guidance about when to start and how often to perform mammography continues to confuse patients and clinicians, complicating shared decision‑making. Experts urge individualized risk assessment and clearer communication of benefits and harms to reduce both undertreatment and unnecessary anxiety, because apparently screening schedules enjoy being controversial.

#healthcare #publichealth #cancerresearch #cancerscreening #diagnostics

Patient confusion over mammogram timing

15 days / medicalxpress

15 days / abcnews


Risk-based screening: AI and trials

8 days / nature

14 days / oncodaily


USPSTF political shake-up threatens screening guidance

11 days / abcnews


All Other Stories

3 days / bbc

3 days / bbc


Back to Top / Saturday, May 16, 2026, 4:21 pm / permalink 23911 / 12 stories in 15 days /

Canadian from hantavirus-hit cruise ship tests positive

bbc - The individual is one of four former passengers on the MV Hondius isolating on Vancouver Island, British Columbia.

AI Summary: A Canadian passenger tested positive after an Andes‑virus outbreak aboard a cruise ship, and French authorities report the strain matches known South American viruses. Public health teams began targeted testing, contact tracing and onboard monitoring as experts debate what constitutes “close contact,” balancing realistic containment with the mild panic such exotic pathogens tend to inspire.

#publichealth #governmentpolicy #wildlife #zoonoticdisease #infectiousdisease #diagnostics

Canada confirms hantavirus cases; testing and isolation underway

14 days / medicalxpress

14 days / medicalxpress

15 days / bbc


Defining close contact: contact‑tracing challenges and outbreaks at sea

13 days / medicalxpress

15 days / livescience


Sequencing shows South American strain; ship arrival and WHO stance

13 days / medicalxpress

13 days / abcnews

15 days / medicalxpress


All Other Stories

4 days / medicalxpress

5 days / abcnews

5 days / medicalxpress

8 days / medicalxpress

9 days / medicalxpress

9 days / medicalxpress

11 days / medicalxpress

11 days / medicalxpress

11 days / medicalxpress

12 days / abcnews

12 days / medicalxpress

13 days / abcnews


Back to Top / Saturday, May 16, 2026, 4:21 pm / permalink 23910 / 24 stories in 15 days /

Historical DNA Links Colonial Graves to 1.3 Million Living Relatives and May Have Identified the Colony’s Second Governor

discovermagazine - Learn how researchers used DNA and 23andMe to connect 17th-century Maryland colonists to more than 1.3 million living people and potentially identify the colony’s second governor.

AI Summary: Ancient DNA from a colonial‑era burial site has been analyzed and linked to living descendants, potentially identifying one of the colony’s leaders. Among the finds is an 8‑year‑old African American boy buried with white colonists; researchers report his presence but cannot yet determine whether he was enslaved, prompting fresh questions about social status and burial practices.

#biotech #genetics

4 days / livescience

8 days / livescience

10 days / livescience

15 days / livescience


Back to Top / Saturday, May 16, 2026, 11:21 am / permalink 23901 / 6 stories in 15 days /

Women’s experiences are forgotten in research on childbirth and breastfeeding

Thomas Saïas, Professeur de psychologie, Université du Québec à Montréal (UQAM) / theconversation - Two studies in the field of perinatal care show how, in the areas of breastfeeding and obstetrics, science prioritizes risk and the baby at the expense of mothers’ well-being.

AI Summary: New analyses show that research into childbirth and breastfeeding repeatedly sidelines women's firsthand experiences, prioritizing clinical metrics over lived realities. Experts warn this gap limits understanding of postpartum challenges, skews policy and perpetuates poorer care. Calls are growing for qualitative measures, patient-centered outcomes and inclusive study designs that actually listen to mothers.

#healthcare #publichealth #governmentpolicy #infanthealth #researchfunding #clinicaltrials #healthdisparities #reproductivehealth

Clinical and policy focus on fetus over mothers' care

5 days / medicalxpress

5 days / medicalxpress

15 days / medicalxpress


Mothers’ experiences ignored in childbirth and breastfeeding research

11 days / medicalxpress

12 days / medicalxpress

17 days / medicalxpress


Women’s pain and reproductive conditions dismissed by medicine

8 days / oncodaily

11 days / bbc

12 days / medicalxpress

14 days / bbc


All Other Stories

3 days / medicalxpress

3 days / medicalxpress

4 days / medicalxpress

4 days / bbc

4 days / medicalxpress

4 days / bbc

4 days / bbc


Back to Top / Saturday, May 16, 2026, 6:21 am / permalink 23888 / 19 stories in 15 days /

Newly discovered, blue-whale-size asteroid will fly super close to Earth Monday — and you can watch it live

livescience - Newly spotted asteroid 2026 JH2, which could be up to 115 feet wide, will fly past Earth closer than some satellites on Monday (May 18). The close approach will be visible to stargazers and can be viewed via livestream.

AI Summary: A newly discovered, blue‑whale‑sized asteroid will make a very close pass by Earth on Monday, offering astronomers and the public a live observational spectacle. Officials stress this is an extraordinary tracking and science opportunity, not a disaster scenario, as teams scramble to collect imagery and spectra to learn about its composition and orbit.

#none

3 days / livescience

3 days / livescience

7 days / livescience

7 days / livescience

15 days / livescience


Back to Top / Saturday, May 16, 2026, 5:21 am / permalink 23887 / 7 stories in 15 days /

Sleep and diet may matter more than exercise for buffering the health toll of chronic stress

Nick Turner, Professor and Future Fund Chair in Leadership, Haskayne School of Business, University / theconversation - A 10-year study of nearly 3,000 Canadian workers finds that sleep quality and diet do more to protect health under chronic work stress than exercise.

AI Summary: New research suggests sleep quality and dietary patterns buffer the physiological harms of chronic stress more effectively than exercise alone. The findings point to prioritizing sleep and nutrition in stress mitigation programs and clinical advice, reminding clinicians and patients that the obvious — rest and real food — still matter more than the latest workout trend.

#healthcare #publichealth #behavioralhealth #nutrition #neuroscience

4 days / medicalxpress

4 days / medicalxpress

9 days / sciencedaily

10 days / medicalxpress

17 days / medicalxpress


Back to Top / Saturday, May 16, 2026, 4:21 am / permalink 23884 / 6 stories in 15 days /

Depressed mice successfully treated with smart contact lenses that zap their brains: New study

medicalxpress - Scientists in South Korea have developed experimental contact lenses designed to send electrical signals through the retina and into brain regions linked to mood. In mice, the technology appeared to improve depression-like behavior.

AI Summary: Preclinical studies report smart contact lenses that deliver tiny electrical signals can reduce depressive-like behaviors in mice, matching effects seen with standard antidepressants. Researchers caution the work is early — promising biologically, but still a long way from fashionable therapeutic eyewear for humans — and will require safety, dosing and translational studies before any clinic-ready hype.

#biotech #digitalhealth #medicaldevices #behavioralhealth #neuroscience

7 days / medicalxpress

8 days / medicalxpress

11 days / medicalxpress

17 days / medicalxpress

17 days / medicalxpress


Back to Top / Saturday, May 16, 2026, 4:21 am / permalink 23883 / 6 stories in 15 days /

Prosecutors seek NYU hospital information on gender-affirming care for children

abcnews - A New York health care system has received a federal grand jury subpoena issued in Texas seeking information about children who received gender-affirming care and the medical providers who administered it

AI Summary: Federal prosecutors have issued a subpoena seeking NYU Langone medical records related to gender-affirming care for minors, escalating legal scrutiny of hospital practices. Authorities are pursuing documentation and communications as part of an inquiry into pediatric services; the move could prompt broader institutional reviews and legal battles over patient privacy and standards of care.

#healthcare #publichealth #governmentpolicy #behavioralhealth #hospitaloperations #adolescenthealth #healthit

13 days / medicalxpress

19 days / abcnews


Back to Top / Saturday, May 16, 2026, 3:21 am / permalink 23882 / 5 stories in 15 days /

Omid Veiseh: First-in-Human Clinical Trial of IL-2 Cytokine Factories in Refractory Ovarian Cancer

oncodaily - Omid Veiseh, Professor and CPRIT Scholar in Cancer Research at Rice University and Co-Founder and Managing Partner of RBL LLC, shared a post on LinkedIn: “Excited to publish the results […]

AI Summary: A first‑in‑human trial of implantable IL‑2 “cytokine factories” in refractory ovarian cancer reported encouraging early safety and biological activity, offering a localized immune‑stimulation strategy that may boost tumor responses while avoiding systemic toxicity. Investigators described the device‑based platform as a potential option for patients with limited alternatives, pending larger efficacy studies.

#pharmaceuticals #biotech #drugdevelopment #medicaldevices #oncology #cancerresearch #clinicaltrials

9 days / medicalxpress

18 days / oncodaily

19 days / medicalxpress


Back to Top / Saturday, May 16, 2026, 2:21 am / permalink 23880 / 4 stories in 15 days /

FDA clears 1st AI sepsis monitoring tool

Giles Bruce / beckershospitalreview - A tool from tech company Bayesian Health has become the first continuous AI sepsis monitor to gain FDA approval. The solution monitors hospital patients to detect deterioration and flag sepsis early on. The application was developed at Baltimore-based Joh…

AI Summary: Regulators have cleared the first AI‑driven sepsis early‑warning system for clinical deployment, enabling hospitals to use algorithmic alerts to identify patients at risk of deterioration earlier. The clearance opens the door for broader adoption of AI in acute care while renewing debates about clinical oversight, false alarms and integration into existing workflows.

#healthcare #publichealth #fda #digitalhealth #medicaldevices #hospitaloperations #infectiousdisease #healthit #diagnostics

15 days / nature

19 days / medicalxpress


Back to Top / Saturday, May 16, 2026, 1:21 am / permalink 23878 / 7 stories in 15 days /

Positive VOLGA Phase III Results for Imfinzi Plus Neoadjuvant EV in MIBC

oncodaily - On May 14, 2026, AstraZeneca announced positive high-level results from a planned interim analysis of the Phase III VOLGA trial, evaluating perioperative Imfinzi with or without Imjudo in combination with […]

AI Summary: Phase III VOLGA trial results reveal that combining durvalumab (Imfinzi) with neoadjuvant enfortumab vedotin improved survival outcomes in muscle‑invasive bladder cancer. Investigators and industry voices highlight potential practice-changing implications for perioperative therapy, while stakeholders weigh regulatory filings and integration into treatment guidelines. Clinicians will want full datasets and toxicity details.

#healthcare #pharmaceuticals #biotech #drugdevelopment #fda #oncology #cancerresearch #clinicaltrials

Clinician reactions, biology and resistance concerns

13 days / medicalxpress

14 days / oncodaily

15 days / oncodaily

17 days / oncodaily


Global GU oncology meetings and community coverage

11 days / oncodaily

13 days / oncodaily

15 days / oncodaily


VOLGA Phase III readout and regulatory landscape

15 days / oncodaily

16 days / oncodaily


All Other Stories

8 days / oncodaily

9 days / oncodaily

9 days / oncodaily

9 days / oncodaily

10 days / medicalxpress

10 days / oncodaily

10 days / oncodaily

10 days / esmo

11 days / oncodaily

13 days / oncodaily


Back to Top / Saturday, May 16, 2026, 12:21 am / permalink 23872 / 20 stories in 15 days /

What to know about new Ebola outbreak that has killed 65 people in Congo

medicalxpress - Africa's top public health body has confirmed a new Ebola outbreak in Congo's Ituri province, the 17th since the disease first emerged in the country in 1976.

AI Summary: Health authorities have confirmed a fresh Ebola outbreak in a remote province of the Democratic Republic of Congo that has killed roughly 65 people. Public-health teams are scrambling to trace contacts, ramp up surveillance, and deploy vaccines and treatments amid logistical and security hurdles. Containment hinges on rapid mobilization and local cooperation.

#healthcare #publichealth #cdc #zoonoticdisease #infectiousdisease #supplychain #ruralhealth

Confirmed Ituri outbreak: cases, deaths and on-the-ground response

16 days / medicalxpress

16 days / abcnews

16 days / medicalxpress

16 days / abcnews


Vaccine shortages, high lethality and push for new vaccines

13 days / newscientist

15 days / medicalxpress

15 days / medicalxpress


WHO declares global health emergency; international response underway

13 days / medicalxpress

13 days / abcnews

14 days / medicalxpress

14 days / medicalxpress


All Other Stories

9 days / livescience

9 days / medicalxpress

9 days / newscientist

9 days / bbc

9 days / bbc

9 days / medicalxpress

9 days / medicalxpress

10 days / abcnews

11 days / medicalxpress

11 days / abcnews

11 days / medicalxpress

11 days / abcnews

11 days / abcnews

11 days / medicalxpress

11 days / medicalxpress

12 days / medicalxpress

12 days / medicalxpress

12 days / medicalxpress

12 days / medicalxpress

12 days / medicalxpress

12 days / bbc

12 days / abcnews

12 days / medicalxpress

12 days / medicalxpress

13 days / medicalxpress

13 days / medicalxpress

13 days / medicalxpress

13 days / livescience

13 days / medicalxpress


Back to Top / Saturday, May 16, 2026, 12:21 am / permalink 23870 / 52 stories in 15 days /



StackHealth RSS


You can now follow topics by RSS - browse the complete list of topics, people, and organizations. Or, try Pancreatic Cancer, Price Transparency, Government Policy, Medicare Advantage (not listed) and look for the RSS link.

More StackHealth





NorthFeed Inc. Terms and Conditions / Privacy Policy

Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.